Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related ECYT
Wedbush Securities Sees Dose Escalation Trials Continue Without Toxicity Signals For Endocyte
Why Endocyte Could Be Positioned For A Surge
Can The Uptrend Continue for Endocyte (ECYT)? - Tale of the Tape (Zacks)
Related SREV
Morning Market Gainers
Morning Market Losers

Endocyte (NASDAQ: ECYT) shares fell 61.16% to $6.75 in pre-market trading after the company reported first quarter financial results and provided clinical update.

ServiceSource International (NASDAQ: SREV) shares dropped 15.20% to $5.30 in pre-market trading after the company reported downbeat first quarter earnings.

CVS Caremark Corporation (NYSE: CVS) dropped 2.45% to $71.30 in pre-market trading after the company announced an 18% rise in profit for the first quarter.

Expedia Inc. (NASDAQ: EXPE)) dipped 2.21% to $72.44 in pre-market trading on Q1 results.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook

 

Related Articles (CVS + ECYT)

Around the Web, We're Loving...